Triple-drug combo of anti-malaria pill hydroxychloroquine, azithromycin and ZINC improved coronavirus patients' chances of being discharged and cut death risk by almost 50%, study finds

Combining the anti-malaria drug hydroxychloroquine with the dietary supplement zinc could create a more effective treatment for coronavirus patients, a new study suggests.

Researchers found that taking the drugs together, along with the antibiotic azithromycin, increased patient's chances of being discharged and decreased their risk of dying.

It did not, however, change the average time patients spent in hospital, how long they spent on a ventilator or the total amount of oxygen required.

President Donald Trump has often touted the drug as a 'game-changer' during his press conferences and on Twitter, and the US Food and Drug Administration authorized emergency use of hydroxychloroquine.

The team, from New York University Grossman School of Medicine, says the findings are encouraging but that more studies, including a randomized clinical trial, are needed.

More

from Salisbury News https://ift.tt/2zAOR4e